| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.0B | $-0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $0.64 | $0.46 | $-0.03 | $0.69 | $0.42 | $0.30 | $0.51 | $0.31 |
| EPS (Diluted) | $0.64 | $0.46 | $-0.03 | $0.69 | $0.42 | $0.30 | $0.51 | $0.31 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $23.2B | $12.3B | $12.4B | $11.7B | $11.6B | $12.8B | $13.2B | $12.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $2.0B | — | — | — | — | — | $0.6B | $0.2B |
| Total Liabilities | $20.7B | $11.1B | $11.4B | $10.7B | $10.4B | $11.7B | $11.5B | $10.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.5B | $1.2B | $1.0B | $1.0B | $1.2B | $1.2B | $1.8B | $1.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.1B | $0.2B | $0.1B | $0.1B | $0.2B | $0.1B | $0.2B |
| Investing Cash Flow | $2.3B | $-0.3B | $-0.3B | $-1.3B | $0.6B | $0.6B | $1.2B | $-0.9B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-1.0B | $0.1B | $0.6B | $0.2B | $-0.6B | $0.1B | $-0.9B | $0.6B |